Ƶ

Load mobile navigation

Pharmaceuticals

GSK insists it's 'well positioned' as Trump's pharma tariffs loom
By City AM
The FTSE 100 drugmaker said it was "well positioned" to tackle the impact of sector-specific tariffs as speculation mounts that President Donald Trump is preparing to target pharmaceutical imports
Bookmark
Newcastle tech firm QuantuMDx narrows losses amid upgrade to pioneering health device
Technology
The firm's Q-POC device aims to provide diagnoses for a range of illnesses within minutes
Bookmark
Pharma firm Shield Therapeutics warns of 'unpredictability' from US tariffs
Company Results
The commercial stage business has significantly boosted prescriptions and narrowed losses
Bookmark
Astrazeneca CEO blasts Europe for 'putting health of its people at risk'
By City AM
CEO Pascal Soriot said Europe was "falling behind" in attracting investment and needed to "invest more in what really matters to it"
Bookmark
Shield Therapeutics signs licence deal with Vital-Net to break into Japan
Deals
The Gateshead pharmaceutical firm has received an initial payment of $665,000 as part of the exclusive licence agreement
Bookmark
Biotech business Atelerix signs distribution deal to expand into China
Deals
The firm has signed an exclusive distribution agreement with MineBio, a leading Chinese supply chain and logistics organisation
Bookmark
Aelius Biotech scientists raise £750,000 to expand overseas presence
Deals
Aelius’s model is the only one of its type that can simulate all three stages of the digestion process – from substances passing through the gut, crossing the mucus layer on its surface and being absorbed into the body.
Bookmark
Newcastle recruitment company Lead Candidate launches own drive for new employees
Pharmaceuticals
The specialist recruitment firm has also moved into a brand new Newcastle city centre head office at 8 Nelson Street
Bookmark
FTSE 100 pharma giants GSK and Astrazeneca may have dodged Trump tariffs
By City AM
Pharmaceutical goods appear to be exempt from higher-rate tariffs introduced by President Trump in his 'Liberation Day' address on Wednesday, according to a City broker
Bookmark
Aptamer Group doubles half-year revenue as firm sees 'strong and sustainable' commercial momentum
Company Results
The Yorl business said it is now signing multiple new contracts with global market-leading pharmaceutical companies
Bookmark
Northumberland life sciences firm seals £500k investment to fund trials for cancer-prevention treatment
Deals
The Alnwick business is poised to draw up a clinical trial for HELIX, the firm's first product being brought to market
Bookmark
Hikma Pharmaceuticals' revenue grows nine per cent to £2.47bn as profit booms
By City AM
The pharmaceutical company said the bulk of its growth came from its North American arm as well as recent product launches
Bookmark
North East life sciences experiencing a wave of optimism - but there are challenges to overcome
Chamber of Commerce
The first of what is hoped to be an annual study of the region's sector is positive but lack of funding, laboratory space and big changes with the US trading relationship pose difficulties for firms
Bookmark
Astrazeneca says it's 'too big' to base CEO's pay packet on FTSE 100 peers
By City AM
Astrazeneca has defended the £14.7 million pay package handed to chief executive Pascal Soriot, saying the group is too big and complex to base his remuneration on the rest of the FTSE 100 index
Bookmark
Healthtech start-up bags Europe's largest pre-seed funding round for female founders
By City AM
Level Zero Health raised the funds to accelerate the development of the world's first remote and continuous hormone monitoring device, powered by first of a kind DNA-based sensors
Bookmark
Historic building in Newcastle signs up three tenants after £1.5m transformation
property news
The former Cafe Royale building will soon welcome Mowgli Street Food alongside two other tenants in upper floor offices
Bookmark
Astrazeneca's revenue soars despite China woes as it 'doesn't pay £700k tax bill'
By City AM
The pharmaceutical giant's revenue jumped 21 per cent last year despite growing troubles over its presence in China, where it is alleged to have not paid a $900,000 importation tax bill
Bookmark
Gateshead drug firm Shield Therapeutics to see revenues rise 84% amid boost in prescriptions
Pharmaceuticals
The firm - which specialises in iron deficiency tablet Accrufer - has announced a “significant step-up in revenue” during 2024
Bookmark
GSK boosts 2031 revenue target to over £40bn following robust Q4 results
By City AM
The pharma giant hiked its 2031 sales forecast to more than £40bn, up from £38bn, after reporting better than forecast fourth quarter earnings.
Bookmark
AstraZeneca halts vaccine plant expansion citing insufficient government support
Pharmaceuticals
The pharmaceutical giant said it was no longer pursuing a £450 million investment in a vaccine manufacturing plant in Merseyside after discussions with the Government
Bookmark
The Newcastle firm making waves in biotech inspired by a four-toed African pygmy hedgehog
Deals
Atelerix - which also takes its name from the hedgehog - has secured more than £1m in funding this year alone
Bookmark
Ƶ government delays 'could threaten' AstraZeneca's new £450m vaccine facility in Liverpool
Pharmaceuticals
Last year it was reported that AstraZeneca was considering moving the manufacturing of its Covid-19 jab overseas amid a 'deadlock' in its talks with the Ƶ government
Bookmark
Tyneside pharma firm Shield Therapeutics appoints new US-based CEO
Appointments
The company said Mr Lundstrom’s interim leadership has been instrumental in driving the firm’s growth
Bookmark
Pharma consultancy Coronado Research creates jobs with Newcastle office launch
Pharmaceuticals
The newly established firm specialises in building models for drug development that can help patients of rare conditions
Bookmark
Story Saved
You can find this story in  My Bookmarks.Or by navigating to the user icon in the top right.